Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes

Clinical Chemistry

Volumn 57, Issue 11, 2011, Pages 1556-1565

  Cangemi, Claudia ^a   Skov, Vibe ^a   Poulsen, Michael Kjaer ^a   Funder, Jonas ^b   Twal, Waleed O ^c   Gall, Mari Anne ^d   Hjortdal, Vibeke ^b   Jespersen, Marie Louise ^b   Kruse, Torben A ^a   Aagard, Jan ^a   Parving, Hans Henrik ^b,e   Knudsen, Steen ^f   Høilund Carlsen, Poul Flemming ^a   Rossing, Peter ^d   Henriksen, Jan Erik ^a   Argraves, William Scott ^c   Rasmussen, Lars Melholt ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d STENO DIABETES CENTER   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f Medical Prognosis Institute A/S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ELASTIN; FIBULIN 1; GELATINASE A; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LEPTIN; MEMBRANE PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; BIOACCUMULATION; BLOOD PRESSURE MEASUREMENT; BODY MASS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ECHOGRAPHY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART STROKE VOLUME; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; MALE; MAMMARY ARTERY; MICROARRAY ANALYSIS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PULSE PRESSURE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; VASCULAR SMOOTH MUSCLE; VASCULAR SURGERY;

AGED; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; MAMMARY ARTERIES; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 80055091636     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.162966     Document Type: Article

References (40)

1. Simmons RK, Coleman RL, Price HC, Holman RR, Khaw KT, Wareham NJ, Griffin SJ. Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC-Norfolk Cohort. Diabetes Care 2009;32:708-13.
2. Preis SR, Pencina MJ, Hwang SJ, D'Agostino RB Sr, Savage PJ, Levy D, Fox CS. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation 2009;120:212-20.
3. Makita S, Matsui H, Naganuma Y, Abiko A, Tamada M, Nakamura M. Diabetic state as a crucial factor for impaired arterial elastic properties in patients with peripheral arterial disease. Atherosclerosis 2009;208:167-70.
4. Sims TJ, Rasmussen LM, Oxlund H, Bailey AJ. The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 1996;39:946-51. (Pubitemid 26249114)
5. Heickendorff L, Ledet T, Rasmussen LM. Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque. Diabetologia 1994;37:286-92. (Pubitemid 24076081)
6. Olesen P, Ledet T, Rasmussen LM. Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha. Diabetologia 2005;48:561-8. (Pubitemid 40487304)
7. Takemoto M, Yokote K, Nishimura M, Shigematsu T, Hasegawa T, Kon S, et al. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. Arterioscler Thromb Vasc Biol 2000;20:624-8. (Pubitemid 30151673)
8. Rasmussen LM, Ledet T. Aortic collagen alterations in human diabetes mellitus. Changes in basement membrane collagen content and in the susceptibility of total collagen to cyanogen bromide solubilisation. Diabetologia 1993;36:445-53. (Pubitemid 23124050)
9. Monnier VM, Kohn RR, Cerami A. Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci U S A 1984; 81:583-7. (Pubitemid 14186609)
10. Oimomi M, Igaki N, Hata F, Kitamura Y, Nishimoto S, Baba S, Maeda S. Age- and diabetes-accelerated glycation in the human aorta. Arch Gerontol Geriatr 1989;8:123-7. (Pubitemid 19078140)
11. Boden G, Song W, Pashko L, Kresge K. In vivo effects of insulin and free fatty acids on matrix metalloproteinases in rat aorta. Diabetes 2008; 57:476-83.
12. Chung AW, Booth AD, Rose C, Thompson CR, Levin A, van BC. Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes and kidney dysfunction. J Vasc Res 2008;45:357-62. (Pubitemid 351793739)
13. Chung AW, Yang HH, Kim JM, Sigrist MK, Chum E, Gourlay WA, Levin A. Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation 2009;120:792-801.
14. Kwan CY, Wang RR, Beazley JS, Lee RM. Alterations of elastin and elastase-like activities in aortae of diabetic rats. Biochim Biophys Acta 1988; 967:322-5. (Pubitemid 18265692)
15. Tanno T, Yoshinaga K, Sato T. Alteration of elastin in aorta from diabetics. Atherosclerosis 1993; 101:129-34. (Pubitemid 23214225)
16. McDonald TO, Gerrity RG, Jen C, Chen HJ, Wark K, Wight TN, et al. Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis. J Histochem Cytochem 2007;55: 1149-57. (Pubitemid 350006297)
17. Poulsen MK, Henriksen JE, Dahl J, Johansen A, Moller JE, Gerke O, et al. Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients. J Nucl Cardiol 2009;16:878-87.
18. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995;44:1303-9.
19. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003;362:759-66. (Pubitemid 37093915)
20. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization appliedto microarray data calibration and to the quantification of differential expression. Bioinformatics 2002;18(Suppl 1):S96-104.
21. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 2001;98:31-6. (Pubitemid 32095858)
22. Argraves WS, Tran H, Burgess WH, Dickerson K. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J Cell Biol 1990;111:3155-64. (Pubitemid 120034050)
23. Poulsen MK, Henriksen JE, Dahl J, Johansen A, Gerke O, Vach W, et al. Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease. Circ Cardiovasc Imaging 2009.
24. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108. (Pubitemid 43257193)
25. Argraves WS, Greene LM, Cooley MA, Gallagher WM. Fibulins: physiological and disease perspectives. EMBO Rep 2003;4:1127-31. (Pubitemid 38088406)
26. Kobayashi N, Kostka G, Garbe JH, Keene DR, Bachinger HP, Hanisch FG, et al. A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization. J Biol Chem 2007;282:11805-16. (Pubitemid 47100695)
27. Roark EF, Keene DR, Haudenschild CC, Godyna S, Little CD, Argraves WS. The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J Histochem Cytochem 1995;43:401-11.
28. Kostka G, Giltay R, Bloch W, Addicks K, Timpl R, Fassler R, Chu ML. Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice. Mol Cell Biol 2001;21:7025-34. (Pubitemid 32911262)
29. Cooley MA, Kern CB, Fresco VM, Wessels A, Thompson RP, McQuinn TC, et al. Fibulin-1 is required for morphogenesis of neural crestderived structures. Dev Biol 2008;319:336-45.
30. Argraves WS, Tanaka A, Smith EP, Twal WO, Argraves KM, Fan D, Haudenschild CC. Fibulin-1 and fibrinogen in human atherosclerotic lesions. Histochem Cell Biol 2009;132:559-65.
31. Mohamed SA, Sievers HH, Hanke T, Richardt D, Schmidtke C, Charitos EI, et al. Pathway analysis of differentially expressed genes in patients with acute aortic dissection. Biomark Insights 2009;4: 81-90.
32. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG. Human 92- and 72- kilodalton type IV collagenases are elastases. J Biol Chem 1991;266:7870-5.
33. Wada J, Zhang H, Tsuchiyama Y, Hiragushi K, Hida K, Shikata K, et al. Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis. Kidney Int 2001; 59:1363-73. (Pubitemid 32281224)
34. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-605. (Pubitemid 44627304)
35. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002;106:2085-90. (Pubitemid 35192814)
36. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008;51:527-39.
37. Sharman JE, Haluska BA, Fang ZY, Prins JB, Marwick TH. Association of arterial wave properties and diastolic dysfunction in patients with type 2 diabetes mellitus. Am J Cardiol 2007;99:844-8. (Pubitemid 46365605)
38. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25:932-43. (Pubitemid 40627836)
39. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 2000;101:2271-6.
40. Yki-Jarvinen H, Westerbacka J. Insulin resistance, arterial stiffness and wave reflection. Adv Cardiol 2007;44:252-60.